Essex Bio-Technology Limited 1061.HK Stock
Essex Bio-Technology Limited Price Chart
Essex Bio-Technology Limited 1061.HK Financial and Trading Overview
| Essex Bio-Technology Limited stock price | 2.25 HKD |
| Previous Close | 3.6 HKD |
| Open | 3.64 HKD |
| Bid | 3.6 HKD x 0 |
| Ask | 3.64 HKD x 0 |
| Day's Range | 3.64 - 3.64 HKD |
| 52 Week Range | 2.95 - 4.51 HKD |
| Volume | 4K HKD |
| Avg. Volume | 110.91K HKD |
| Market Cap | 2.08B HKD |
| Beta (5Y Monthly) | 0.526436 |
| PE Ratio (TTM) | 9.578948 |
| EPS (TTM) | 0.47 HKD |
| Forward Dividend & Yield | 0.07 (1.79%) |
| Ex-Dividend Date | June 13, 2023 |
| 1y Target Est | N/A |
1061.HK Valuation Measures
| Enterprise Value | 2B HKD |
| Trailing P/E | 9.578948 |
| Forward P/E | 13.481482 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.576342 |
| Price/Book (mrq) | 1.2017168 |
| Enterprise Value/Revenue | 1.521 |
| Enterprise Value/EBITDA | 5.96 |
Trading Information
Essex Bio-Technology Limited Stock Price History
| Beta (5Y Monthly) | 0.526436 |
| 52-Week Change | 1.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.51 HKD |
| 52 Week Low | 2.95 HKD |
| 50-Day Moving Average | 3.65 HKD |
| 200-Day Moving Average | 3.74 HKD |
1061.HK Share Statistics
| Avg. Volume (3 month) | 110.91K HKD |
| Avg. Daily Volume (10-Days) | 27.8K HKD |
| Shares Outstanding | 570.65M |
| Float | 264.46M |
| Short Ratio | N/A |
| % Held by Insiders | 53.67% |
| % Held by Institutions | 4.77% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.065 |
| Trailing Annual Dividend Yield | 1.80% |
| 5 Year Average Dividend Yield | 155.00% |
| Payout Ratio | 0.2482 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 17.10% |
| Operating Margin (ttm) | 22.91% |
| Gross Margin | 90.25% |
| EBITDA Margin | 25.51% |
Management Effectiveness
| Return on Assets (ttm) | 6.76% |
| Return on Equity (ttm) | 13.00% |
Income Statement
| Revenue (ttm) | 1.32B HKD |
| Revenue Per Share (ttm) | 2.3 HKD |
| Quarterly Revenue Growth (yoy) | -26.50% |
| Gross Profit (ttm) | 1.19B HKD |
| EBITDA | 336.24M HKD |
| Net Income Avi to Common (ttm) | 225.41M HKD |
| Diluted EPS (ttm) | 0.38 |
| Quarterly Earnings Growth (yoy) | -53.10% |
Balance Sheet
| Total Cash (mrq) | 543.49M HKD |
| Total Cash Per Share (mrq) | 0.95 HKD |
| Total Debt (mrq) | 489.73M HKD |
| Total Debt/Equity (mrq) | 28.29 HKD |
| Current Ratio (mrq) | 2.164 |
| Book Value Per Share (mrq) | 3.029 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 382.79M HKD |
| Levered Free Cash Flow (ttm) | 65.84M HKD |
Profile of Essex Bio-Technology Limited
| Country | Hong Kong |
| State | N/A |
| City | Zhuhai |
| Address | No. 88 Keji 6th Road |
| ZIP | N/A |
| Phone | 86 75 6391 1188 |
| Website | https://www.essexbio.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1471 |
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells bio-pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and mouth wash Granules, as well as biologic drugs. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.
Q&A For Essex Bio-Technology Limited Stock
What is a current 1061.HK stock price?
Essex Bio-Technology Limited 1061.HK stock price today per share is 2.25 HKD.
How to purchase Essex Bio-Technology Limited stock?
You can buy 1061.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Essex Bio-Technology Limited?
The stock symbol or ticker of Essex Bio-Technology Limited is 1061.HK.
Which industry does the Essex Bio-Technology Limited company belong to?
The Essex Bio-Technology Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Essex Bio-Technology Limited have in circulation?
The max supply of Essex Bio-Technology Limited shares is 567.54M.
What is Essex Bio-Technology Limited Price to Earnings Ratio (PE Ratio)?
Essex Bio-Technology Limited PE Ratio is 4.78723400 now.
What was Essex Bio-Technology Limited earnings per share over the trailing 12 months (TTM)?
Essex Bio-Technology Limited EPS is 0.47 HKD over the trailing 12 months.
Which sector does the Essex Bio-Technology Limited company belong to?
The Essex Bio-Technology Limited sector is Healthcare.